1 Study Coverage 1.1 Human Hepatitis B Immunoglobulin Product Introduction 1.2 Market by Type 1.2.1 Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) 1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) 1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) 1.3 Market by Application 1.3.1 Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hepatitis B Carrier 1.3.3 Hepatitis B Close Contacts 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Hepatitis B Immunoglobulin Sales Estimates and Forecasts 2017-2028 2.2 Global Human Hepatitis B Immunoglobulin Revenue Estimates and Forecasts 2017-2028 2.3 Global Human Hepatitis B Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human Hepatitis B Immunoglobulin Sales by Region 2.4.1 Global Human Hepatitis B Immunoglobulin Sales by Region (2017-2022) 2.4.2 Global Sales Human Hepatitis B Immunoglobulin by Region (2023-2028) 2.5 Global Human Hepatitis B Immunoglobulin Revenue by Region 2.5.1 Global Human Hepatitis B Immunoglobulin Revenue by Region (2017-2022) 2.5.2 Global Human Hepatitis B Immunoglobulin Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Human Hepatitis B Immunoglobulin Sales by Manufacturers 3.1.1 Global Top Human Hepatitis B Immunoglobulin Manufacturers by Sales (2017-2022) 3.1.2 Global Human Hepatitis B Immunoglobulin Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Hepatitis B Immunoglobulin in 2021 3.2 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers 3.2.1 Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers (2017-2022) 3.2.2 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human Hepatitis B Immunoglobulin Revenue in 2021 3.3 Global Human Hepatitis B Immunoglobulin Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human Hepatitis B Immunoglobulin Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Human Hepatitis B Immunoglobulin Sales by Type 4.1.1 Global Human Hepatitis B Immunoglobulin Historical Sales by Type (2017-2022) 4.1.2 Global Human Hepatitis B Immunoglobulin Forecasted Sales by Type (2023-2028) 4.1.3 Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) 4.2 Global Human Hepatitis B Immunoglobulin Revenue by Type 4.2.1 Global Human Hepatitis B Immunoglobulin Historical Revenue by Type (2017-2022) 4.2.2 Global Human Hepatitis B Immunoglobulin Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) 4.3 Global Human Hepatitis B Immunoglobulin Price by Type 4.3.1 Global Human Hepatitis B Immunoglobulin Price by Type (2017-2022) 4.3.2 Global Human Hepatitis B Immunoglobulin Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Human Hepatitis B Immunoglobulin Sales by Application 5.1.1 Global Human Hepatitis B Immunoglobulin Historical Sales by Application (2017-2022) 5.1.2 Global Human Hepatitis B Immunoglobulin Forecasted Sales by Application (2023-2028) 5.1.3 Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) 5.2 Global Human Hepatitis B Immunoglobulin Revenue by Application 5.2.1 Global Human Hepatitis B Immunoglobulin Historical Revenue by Application (2017-2022) 5.2.2 Global Human Hepatitis B Immunoglobulin Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) 5.3 Global Human Hepatitis B Immunoglobulin Price by Application 5.3.1 Global Human Hepatitis B Immunoglobulin Price by Application (2017-2022) 5.3.2 Global Human Hepatitis B Immunoglobulin Price Forecast by Application (2023-2028) 6 North America 6.1 North America Human Hepatitis B Immunoglobulin Market Size by Type 6.1.1 North America Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) 6.1.2 North America Human Hepatitis B Immunoglobulin Revenue by Type (2017-2028) 6.2 North America Human Hepatitis B Immunoglobulin Market Size by Application 6.2.1 North America Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) 6.2.2 North America Human Hepatitis B Immunoglobulin Revenue by Application (2017-2028) 6.3 North America Human Hepatitis B Immunoglobulin Market Size by Country 6.3.1 North America Human Hepatitis B Immunoglobulin Sales by Country (2017-2028) 6.3.2 North America Human Hepatitis B Immunoglobulin Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Human Hepatitis B Immunoglobulin Market Size by Type 7.1.1 Europe Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) 7.1.2 Europe Human Hepatitis B Immunoglobulin Revenue by Type (2017-2028) 7.2 Europe Human Hepatitis B Immunoglobulin Market Size by Application 7.2.1 Europe Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) 7.2.2 Europe Human Hepatitis B Immunoglobulin Revenue by Application (2017-2028) 7.3 Europe Human Hepatitis B Immunoglobulin Market Size by Country 7.3.1 Europe Human Hepatitis B Immunoglobulin Sales by Country (2017-2028) 7.3.2 Europe Human Hepatitis B Immunoglobulin Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Human Hepatitis B Immunoglobulin Market Size by Type 8.1.1 Asia Pacific Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) 8.1.2 Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Type (2017-2028) 8.2 Asia Pacific Human Hepatitis B Immunoglobulin Market Size by Application 8.2.1 Asia Pacific Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) 8.2.2 Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Application (2017-2028) 8.3 Asia Pacific Human Hepatitis B Immunoglobulin Market Size by Region 8.3.1 Asia Pacific Human Hepatitis B Immunoglobulin Sales by Region (2017-2028) 8.3.2 Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Human Hepatitis B Immunoglobulin Market Size by Type 9.1.1 Latin America Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) 9.1.2 Latin America Human Hepatitis B Immunoglobulin Revenue by Type (2017-2028) 9.2 Latin America Human Hepatitis B Immunoglobulin Market Size by Application 9.2.1 Latin America Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) 9.2.2 Latin America Human Hepatitis B Immunoglobulin Revenue by Application (2017-2028) 9.3 Latin America Human Hepatitis B Immunoglobulin Market Size by Country 9.3.1 Latin America Human Hepatitis B Immunoglobulin Sales by Country (2017-2028) 9.3.2 Latin America Human Hepatitis B Immunoglobulin Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Human Hepatitis B Immunoglobulin Market Size by Type 10.1.1 Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Type (2017-2028) 10.2 Middle East and Africa Human Hepatitis B Immunoglobulin Market Size by Application 10.2.1 Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Application (2017-2028) 10.3 Middle East and Africa Human Hepatitis B Immunoglobulin Market Size by Country 10.3.1 Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Baxter 11.1.1 Baxter Corporation Information 11.1.2 Baxter Overview 11.1.3 Baxter Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Baxter Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Baxter Recent Developments 11.2 CSL 11.2.1 CSL Corporation Information 11.2.2 CSL Overview 11.2.3 CSL Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 CSL Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 CSL Recent Developments 11.3 Bayer 11.3.1 Bayer Corporation Information 11.3.2 Bayer Overview 11.3.3 Bayer Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Bayer Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bayer Recent Developments 11.4 Grifols 11.4.1 Grifols Corporation Information 11.4.2 Grifols Overview 11.4.3 Grifols Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Grifols Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Grifols Recent Developments 11.5 Octapharma 11.5.1 Octapharma Corporation Information 11.5.2 Octapharma Overview 11.5.3 Octapharma Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Octapharma Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Octapharma Recent Developments 11.6 Shanghai RAAS 11.6.1 Shanghai RAAS Corporation Information 11.6.2 Shanghai RAAS Overview 11.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Shanghai RAAS Recent Developments 11.7 Hualan Biological 11.7.1 Hualan Biological Corporation Information 11.7.2 Hualan Biological Overview 11.7.3 Hualan Biological Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Hualan Biological Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Hualan Biological Recent Developments 11.8 China Biologic 11.8.1 China Biologic Corporation Information 11.8.2 China Biologic Overview 11.8.3 China Biologic Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 China Biologic Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 China Biologic Recent Developments 11.9 Tiantan Biologic 11.9.1 Tiantan Biologic Corporation Information 11.9.2 Tiantan Biologic Overview 11.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Tiantan Biologic Recent Developments 11.10 Shuanglin Bio-pharmacy 11.10.1 Shuanglin Bio-pharmacy Corporation Information 11.10.2 Shuanglin Bio-pharmacy Overview 11.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Shuanglin Bio-pharmacy Recent Developments 11.11 Sichuan Yuanda Shuyang 11.11.1 Sichuan Yuanda Shuyang Corporation Information 11.11.2 Sichuan Yuanda Shuyang Overview 11.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Sichuan Yuanda Shuyang Recent Developments 11.12 Boya Bio-pharmaceutical 11.12.1 Boya Bio-pharmaceutical Corporation Information 11.12.2 Boya Bio-pharmaceutical Overview 11.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Boya Bio-pharmaceutical Recent Developments 11.13 Shanghai Institute of Biological 11.13.1 Shanghai Institute of Biological Corporation Information 11.13.2 Shanghai Institute of Biological Overview 11.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Shanghai Institute of Biological Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Human Hepatitis B Immunoglobulin Industry Chain Analysis 12.2 Human Hepatitis B Immunoglobulin Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human Hepatitis B Immunoglobulin Production Mode & Process 12.4 Human Hepatitis B Immunoglobulin Sales and Marketing 12.4.1 Human Hepatitis B Immunoglobulin Sales Channels 12.4.2 Human Hepatitis B Immunoglobulin Distributors 12.5 Human Hepatitis B Immunoglobulin Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human Hepatitis B Immunoglobulin Industry Trends 13.2 Human Hepatitis B Immunoglobulin Market Drivers 13.3 Human Hepatitis B Immunoglobulin Market Challenges 13.4 Human Hepatitis B Immunoglobulin Market Restraints 14 Key Findings in The Global Human Hepatitis B Immunoglobulin Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Table 3. Major Manufacturers of 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Table 4. Major Manufacturers of 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Table 5. Global Human Hepatitis B Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Human Hepatitis B Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Human Hepatitis B Immunoglobulin Sales by Region (2017-2022) & (K MT) Table 8. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2017-2022) Table 9. Global Human Hepatitis B Immunoglobulin Sales by Region (2023-2028) & (K MT) Table 10. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2023-2028) Table 11. Global Human Hepatitis B Immunoglobulin Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2017-2022) Table 13. Global Human Hepatitis B Immunoglobulin Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region (2023-2028) Table 15. Global Human Hepatitis B Immunoglobulin Sales by Manufacturers (2017-2022) & (K MT) Table 16. Global Human Hepatitis B Immunoglobulin Sales Share by Manufacturers (2017-2022) Table 17. Global Human Hepatitis B Immunoglobulin Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Human Hepatitis B Immunoglobulin Revenue Share by Manufacturers (2017-2022) Table 19. Human Hepatitis B Immunoglobulin Price by Manufacturers (2017-2022) &(USD/MT) Table 20. Global Human Hepatitis B Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Human Hepatitis B Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hepatitis B Immunoglobulin as of 2021) Table 22. Human Hepatitis B Immunoglobulin Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Human Hepatitis B Immunoglobulin Product Offered Table 24. Date of Manufacturers Enter into Human Hepatitis B Immunoglobulin Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Human Hepatitis B Immunoglobulin Sales by Type (2017-2022) & (K MT) Table 27. Global Human Hepatitis B Immunoglobulin Sales by Type (2023-2028) & (K MT) Table 28. Global Human Hepatitis B Immunoglobulin Sales Share by Type (2017-2022) Table 29. Global Human Hepatitis B Immunoglobulin Sales Share by Type (2023-2028) Table 30. Global Human Hepatitis B Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Human Hepatitis B Immunoglobulin Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Human Hepatitis B Immunoglobulin Revenue Share by Type (2017-2022) Table 33. Global Human Hepatitis B Immunoglobulin Revenue Share by Type (2023-2028) Table 34. Human Hepatitis B Immunoglobulin Price by Type (2017-2022) & (USD/MT) Table 35. Global Human Hepatitis B Immunoglobulin Price Forecast by Type (2023-2028) & (USD/MT) Table 36. Global Human Hepatitis B Immunoglobulin Sales by Application (2017-2022) & (K MT) Table 37. Global Human Hepatitis B Immunoglobulin Sales by Application (2023-2028) & (K MT) Table 38. Global Human Hepatitis B Immunoglobulin Sales Share by Application (2017-2022) Table 39. Global Human Hepatitis B Immunoglobulin Sales Share by Application (2023-2028) Table 40. Global Human Hepatitis B Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Human Hepatitis B Immunoglobulin Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Human Hepatitis B Immunoglobulin Revenue Share by Application (2017-2022) Table 43. Global Human Hepatitis B Immunoglobulin Revenue Share by Application (2023-2028) Table 44. Human Hepatitis B Immunoglobulin Price by Application (2017-2022) & (USD/MT) Table 45. Global Human Hepatitis B Immunoglobulin Price Forecast by Application (2023-2028) & (USD/MT) Table 46. North America Human Hepatitis B Immunoglobulin Sales by Type (2017-2022) & (K MT) Table 47. North America Human Hepatitis B Immunoglobulin Sales by Type (2023-2028) & (K MT) Table 48. North America Human Hepatitis B Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Human Hepatitis B Immunoglobulin Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Human Hepatitis B Immunoglobulin Sales by Application (2017-2022) & (K MT) Table 51. North America Human Hepatitis B Immunoglobulin Sales by Application (2023-2028) & (K MT) Table 52. North America Human Hepatitis B Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Human Hepatitis B Immunoglobulin Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Human Hepatitis B Immunoglobulin Sales by Country (2017-2022) & (K MT) Table 55. North America Human Hepatitis B Immunoglobulin Sales by Country (2023-2028) & (K MT) Table 56. North America Human Hepatitis B Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Human Hepatitis B Immunoglobulin Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Human Hepatitis B Immunoglobulin Sales by Type (2017-2022) & (K MT) Table 59. Europe Human Hepatitis B Immunoglobulin Sales by Type (2023-2028) & (K MT) Table 60. Europe Human Hepatitis B Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Human Hepatitis B Immunoglobulin Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Human Hepatitis B Immunoglobulin Sales by Application (2017-2022) & (K MT) Table 63. Europe Human Hepatitis B Immunoglobulin Sales by Application (2023-2028) & (K MT) Table 64. Europe Human Hepatitis B Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Human Hepatitis B Immunoglobulin Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Human Hepatitis B Immunoglobulin Sales by Country (2017-2022) & (K MT) Table 67. Europe Human Hepatitis B Immunoglobulin Sales by Country (2023-2028) & (K MT) Table 68. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Human Hepatitis B Immunoglobulin Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Type (2017-2022) & (K MT) Table 71. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Type (2023-2028) & (K MT) Table 72. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Application (2017-2022) & (K MT) Table 75. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Application (2023-2028) & (K MT) Table 76. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Region (2017-2022) & (K MT) Table 79. Asia Pacific Human Hepatitis B Immunoglobulin Sales by Region (2023-2028) & (K MT) Table 80. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Human Hepatitis B Immunoglobulin Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Human Hepatitis B Immunoglobulin Sales by Type (2017-2022) & (K MT) Table 83. Latin America Human Hepatitis B Immunoglobulin Sales by Type (2023-2028) & (K MT) Table 84. Latin America Human Hepatitis B Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Human Hepatitis B Immunoglobulin Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Human Hepatitis B Immunoglobulin Sales by Application (2017-2022) & (K MT) Table 87. Latin America Human Hepatitis B Immunoglobulin Sales by Application (2023-2028) & (K MT) Table 88. Latin America Human Hepatitis B Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Human Hepatitis B Immunoglobulin Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Human Hepatitis B Immunoglobulin Sales by Country (2017-2022) & (K MT) Table 91. Latin America Human Hepatitis B Immunoglobulin Sales by Country (2023-2028) & (K MT) Table 92. Latin America Human Hepatitis B Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Human Hepatitis B Immunoglobulin Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Type (2017-2022) & (K MT) Table 95. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Type (2023-2028) & (K MT) Table 96. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Application (2017-2022) & (K MT) Table 99. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Application (2023-2028) & (K MT) Table 100. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2017-2022) & (K MT) Table 103. Middle East and Africa Human Hepatitis B Immunoglobulin Sales by Country (2023-2028) & (K MT) Table 104. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue by Country (2023-2028) & (US$ Million) Table 106. Baxter Corporation Information Table 107. Baxter Description and Major Businesses Table 108. Baxter Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 109. Baxter Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Baxter Recent Developments Table 111. CSL Corporation Information Table 112. CSL Description and Major Businesses Table 113. CSL Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 114. CSL Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 115. CSL Recent Developments Table 116. Bayer Corporation Information Table 117. Bayer Description and Major Businesses Table 118. Bayer Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 119. Bayer Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Bayer Recent Developments Table 121. Grifols Corporation Information Table 122. Grifols Description and Major Businesses Table 123. Grifols Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 124. Grifols Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 125. Grifols Recent Developments Table 126. Octapharma Corporation Information Table 127. Octapharma Description and Major Businesses Table 128. Octapharma Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 129. Octapharma Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 130. Octapharma Recent Developments Table 131. Shanghai RAAS Corporation Information Table 132. Shanghai RAAS Description and Major Businesses Table 133. Shanghai RAAS Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 134. Shanghai RAAS Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Shanghai RAAS Recent Developments Table 136. Hualan Biological Corporation Information Table 137. Hualan Biological Description and Major Businesses Table 138. Hualan Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 139. Hualan Biological Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Hualan Biological Recent Developments Table 141. China Biologic Corporation Information Table 142. China Biologic Description and Major Businesses Table 143. China Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 144. China Biologic Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 145. China Biologic Recent Developments Table 146. Tiantan Biologic Corporation Information Table 147. Tiantan Biologic Description and Major Businesses Table 148. Tiantan Biologic Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 149. Tiantan Biologic Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Tiantan Biologic Recent Developments Table 151. Shuanglin Bio-pharmacy Corporation Information Table 152. Shuanglin Bio-pharmacy Description and Major Businesses Table 153. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 154. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 155. Shuanglin Bio-pharmacy Recent Developments Table 156. Sichuan Yuanda Shuyang Corporation Information Table 157. Sichuan Yuanda Shuyang Description and Major Businesses Table 158. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 159. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 160. Sichuan Yuanda Shuyang Recent Developments Table 161. Boya Bio-pharmaceutical Corporation Information Table 162. Boya Bio-pharmaceutical Description and Major Businesses Table 163. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 164. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 165. Boya Bio-pharmaceutical Recent Developments Table 166. Shanghai Institute of Biological Corporation Information Table 167. Shanghai Institute of Biological Description and Major Businesses Table 168. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 169. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications Table 170. Shanghai Institute of Biological Recent Developments Table 171. Key Raw Materials Lists Table 172. Raw Materials Key Suppliers Lists Table 173. Human Hepatitis B Immunoglobulin Distributors List Table 174. Human Hepatitis B Immunoglobulin Customers List Table 175. Human Hepatitis B Immunoglobulin Market Trends Table 176. Human Hepatitis B Immunoglobulin Market Drivers Table 177. Human Hepatitis B Immunoglobulin Market Challenges Table 178. Human Hepatitis B Immunoglobulin Market Restraints Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Human Hepatitis B Immunoglobulin Product Picture Figure 3. Global Human Hepatitis B Immunoglobulin Market Share by Type in 2021 & 2028 Figure 3. 100IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture Figure 4. 200IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture Figure 5. 400IU/Bottle Human Hepatitis B Immunoglobulin (HBIG) Product Picture Figure 6. Global Human Hepatitis B Immunoglobulin Market Share by Application in 2021 & 2028 Figure 7. Hepatitis B Carrier Figure 8. Hepatitis B Close Contacts Figure 9. Human Hepatitis B Immunoglobulin Report Years Considered Figure 10. Global Human Hepatitis B Immunoglobulin Sales 2017-2028 (K MT) Figure 11. Global Human Hepatitis B Immunoglobulin Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Human Hepatitis B Immunoglobulin Revenue 2017-2028 (US$ Million) Figure 13. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 14. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2017-2022) Figure 15. Global Human Hepatitis B Immunoglobulin Sales Market Share by Region (2023-2028) Figure 16. North America Human Hepatitis B Immunoglobulin Sales YoY (2017-2028) & (K MT) Figure 17. North America Human Hepatitis B Immunoglobulin Revenue YoY (2017-2028) & (US$ Million) Figure 18. Europe Human Hepatitis B Immunoglobulin Sales YoY (2017-2028) & (K MT) Figure 19. Europe Human Hepatitis B Immunoglobulin Revenue YoY (2017-2028) & (US$ Million) Figure 20. Asia-Pacific Human Hepatitis B Immunoglobulin Sales YoY (2017-2028) & (K MT) Figure 21. Asia-Pacific Human Hepatitis B Immunoglobulin Revenue YoY (2017-2028) & (US$ Million) Figure 22. Latin America Human Hepatitis B Immunoglobulin Sales YoY (2017-2028) & (K MT) Figure 23. Latin America Human Hepatitis B Immunoglobulin Revenue YoY (2017-2028) & (US$ Million) Figure 24. Middle East & Africa Human Hepatitis B Immunoglobulin Sales YoY (2017-2028) & (K MT) Figure 25. Middle East & Africa Human Hepatitis B Immunoglobulin Revenue YoY (2017-2028) & (US$ Million) Figure 26. The Human Hepatitis B Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 27. The Top 5 and 10 Largest Manufacturers of Human Hepatitis B Immunoglobulin in the World: Market Share by Human Hepatitis B Immunoglobulin Revenue in 2021 Figure 28. Global Human Hepatitis B Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 29. Global Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) Figure 30. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) Figure 31. Global Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) Figure 32. Global Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) Figure 33. North America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) Figure 34. North America Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) Figure 35. North America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) Figure 36. North America Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) Figure 37. North America Human Hepatitis B Immunoglobulin Sales Share by Country (2017-2028) Figure 38. North America Human Hepatitis B Immunoglobulin Revenue Share by Country (2017-2028) Figure 39. U.S. Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 40. Canada Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 41. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) Figure 42. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) Figure 43. Europe Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) Figure 44. Europe Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) Figure 45. Europe Human Hepatitis B Immunoglobulin Sales Share by Country (2017-2028) Figure 46. Europe Human Hepatitis B Immunoglobulin Revenue Share by Country (2017-2028) Figure 47. Germany Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 48. France Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 49. U.K. Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 50. Italy Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 51. Russia Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 52. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) Figure 53. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) Figure 54. Asia Pacific Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) Figure 55. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) Figure 56. Asia Pacific Human Hepatitis B Immunoglobulin Sales Share by Region (2017-2028) Figure 57. Asia Pacific Human Hepatitis B Immunoglobulin Revenue Share by Region (2017-2028) Figure 58. China Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 59. Japan Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 60. South Korea Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 61. India Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 62. Australia Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 63. China Taiwan Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 64. Indonesia Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 65. Thailand Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 66. Malaysia Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 67. Latin America Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) Figure 68. Latin America Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) Figure 69. Latin America Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) Figure 70. Latin America Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) Figure 71. Latin America Human Hepatitis B Immunoglobulin Sales Share by Country (2017-2028) Figure 72. Latin America Human Hepatitis B Immunoglobulin Revenue Share by Country (2017-2028) Figure 73. Mexico Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 74. Brazil Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 75. Argentina Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 76. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Type (2017-2028) Figure 78. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Market Share by Application (2017-2028) Figure 79. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Market Share by Application (2017-2028) Figure 80. Middle East and Africa Human Hepatitis B Immunoglobulin Sales Share by Country (2017-2028) Figure 81. Middle East and Africa Human Hepatitis B Immunoglobulin Revenue Share by Country (2017-2028) Figure 82. Turkey Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 83. Saudi Arabia Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 84. UAE Human Hepatitis B Immunoglobulin Revenue (2017-2028) & (US$ Million) Figure 85. Human Hepatitis B Immunoglobulin Value Chain Figure 86. Human Hepatitis B Immunoglobulin Production Process Figure 87. Channels of Distribution Figure 88. Distributors Profiles Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

Baxter CSL Bayer Grifols Octapharma Shanghai RAAS Hualan Biological China Biologic Tiantan Biologic Shuanglin Bio-pharmacy Sichuan Yuanda Shuyang Boya Bio-pharmaceutical Shanghai Institute of Biological